All Articles

Rithm Property Trust is raising cash to buy multifamily loans from its own manager. Is this a savvy move in a tough market or a risky inside deal?

Avis Budget Group's upcoming Q2 earnings are more than just numbers; they are a referendum on a major strategic reset after a massive EV write-down.

Tavia Acquisition's $450M bet on Vita Inclinata hinges on a pending acquisition, testing investor appetite for complex SPACs in a cautious landscape.

As LandBridge prepares its Q2 report amid falling oil prices, investors watch to see if its bold pivot into digital infrastructure can secure its Permian future.

With a new CEO from the world of high-stakes mining finance, Entrée Resources signals a strategic pivot for its stake in the massive Oyu Tolgoi copper mine.

Commodities giant Glencore transforms a $25M loan into a major equity position in Osisko Metals, signaling a strong bet on Canadian critical minerals.

As WaterBridge prepares its Q2 results, investors are watching. The report offers a crucial look into the high-stakes world of water midstream infrastructure.

Lawson Whiting's retirement triggers a CEO search at the spirits giant. His legacy of premiumization meets a sobering market for his successor.

A 100-year-old Ford Hangar, an architectural marvel by Albert Kahn, is being reimagined as a catalyst for economic growth in the Chicago Southland.

A major Florida acquisition reveals a sophisticated new model for senior housing, blending private equity with data-driven operations to meet a demographic boom.

As HESM preps its Q2 earnings call, the market is watching. Beyond the numbers, it's a test of its fee-based model against Bakken's pulse.

As Hubbell readies its Q2 results, all eyes are on its ability to power the AI boom and grid upgrades. We look beyond the numbers at the strategy behind the surge.

Dynex Capital's 15% dividend yield is a powerful lure for income seekers, but a payout ratio over 100% begs the question: is this a stable return or a risk in disguise?

As Par Pacific prepares its Q2 results, investors will scrutinize how it balanced geopolitical oil price spikes with the pivotal launch of its Hawaii renewables plant.

Eupraxia Pharmaceuticals is overhauling its leadership and relocating to major biotech hubs, betting it all on its late-stage pipeline and a pivotal trial.

Amid record production and surging drilling, PrairieSky's results showcase its resilient royalty model and signal renewed investment vigor in Canada's oil patch.

Amid a disciplined SPAC market resurgence, Samos Energy's new fund targets cash-generating assets, signaling a strategic pivot back to energy security.

A new medical report confirms artificial stone dust causes a fatal, fast-acting lung disease, finding safety controls inadequate and sparking calls for a ban.

Astrana Health is betting big on two veteran executives to scale its AI-driven model. This move isn't just about growth—it's about execution in a booming market.

A defiant press release signals the collapse of a major defense deal. Behind the scenes, a battle over monopolies, pricing, and national security.